Prosecution Insights
Last updated: October 25, 2026

Wilson Sonsini Goodrich & Rosati, P.C.: all pending office actions

← Back to Wilson Sonsini Goodrich & Rosati, P.C.

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19682032 COMPOSITIONS FOR TARGETING MUSCLE CELLS AND USES THEREOF UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. PUTTLITZ, KARL J 1646 §103§112 Non-Final OA — Pending May 19, 2026
19559043 METHODS OF DETERMINING VARIABILITY IN MOLECULAR ALTERATIONS Ellison Institute, LLC KIM, YOUNG J 1681 §103 Final Rejection — Pending Mar 06, 2026
19552942 USE OF 5-HYDROXYMETHYCYTOSINE OR 5-METHYLCYTOSINE FOR DISEASE DETECTION Biomodal Limited WILDER, CYNTHIA B 1681 §101§103§112 Non-Final OA — Pending Feb 27, 2026
19552708 METHODS, SYSTEMS, AND COMPOSITIONS OF GENERATING AND ANALYZING POLYPEPTIDE LIBRARIES Protillion Biosciences, Inc. PLAYER, ROBERT AUSTIN 1686 §103§112Other Final Rejection — Pending Feb 27, 2026
19540128 INHIBITORS OF RIPK2 AND MEDICAL USES THEREOF Odyssey Therapeutics, Inc. CORNET, JEAN P 1628 §103 Final Rejection — Pending Feb 13, 2026
19466032 IL-2 PROCYTOKINE ANTIBODY FUSION PROTEINS Proviva Therapeutics (Hong Kong) Limited TAYLOR, LIA ELAN 1641 §103§112DP Final Rejection — Pending Jan 30, 2026
19452108 METHODS AND SYSTEMS FOR PREDICTIVE ANALYSIS BY MASS SPECTROMETRY Matterworks Inc. LUCK, SEAN M 2878 §102§103§112 Final Rejection — Pending Jan 16, 2026
19415046 PEPTIDE ANALOGS AND METHODS OF USING THE SAME Novo Nordisk A/S CHANDRA, GYAN 1674 §103§112 Non-Final OA — Pending Dec 10, 2025
19383434 COMPOSITIONS FOR THE TREATMENT OF HYPERTENSION The George Institute for Global Health COUGHLIN, DANIEL F 1619 §102 Final Rejection — Pending Nov 07, 2025
19379379 SYSTEMS AND METHODS FOR DETERMINING ACTIONS DURING EMERGENCIES Lifespot Technology, Inc. WALLICK, STEPHANIE SHOSHANA 3628 §101§102§103 Non-Final OA — Pending Nov 04, 2025
19357014 A SYSTEM AND METHOD FOR ULTRASOUND-ENHANCED DELIVERY OF DRUGS Sonikure Holdings Limited FARRAR, LAUREN PENG 3783 §103 Non-Final OA 54d Pending Oct 13, 2025
19344306 METHODS AND SYSTEMS FOR VOLUMETRIC IMAGING Stellaromics, Inc. CARTER, RICHARD BRUCE 2485 DP Non-Final OA — Pending Sep 29, 2025
19330712 SENSOR-BASED MACHINE LEARNING IN A HEALTH PREDICTION ENVIRONMENT Evidation Health, Inc. MISIASZEK, AMBER ALTSCHUL 3682 §101§103 Final Rejection 71d Pending Sep 16, 2025
19307449 HYDROCORTISONE ORAL LIQUID FORMULATIONS Eton Pharmaceuticals, Inc. PIHONAK, SARAH 1627 §103 Final Rejection — Pending Aug 22, 2025
19303640 SYSTEMS AND METHODS FOR METADATA BASED PATH FINDING Datawalk Spólka Akcyjna HOANG, SON T 2169 §103Other Non-Final OA — Pending Aug 19, 2025
19303223 PERSONALIZED WELLNESS SYSTEMS AND METHODS OF USE Onikoroshi, LLC KRIANGCHAIVECH, KETTIP 1686 §101§103DP Final Rejection 30d overdue Pending Aug 18, 2025
19296637 METHODS AND SYSTEMS FOR GENERATING RECOMMENDATIONS FOR HEALTH AND WELLNESS Docfully, Inc. VAN DUZER, ALEXIS KIM 3682 §101§102§103 Non-Final OA — Pending Aug 11, 2025
19292213 PEDIATRIC GARMENT AND METHODS OF MAKING AND USES THEREOF Faith'S Footsies Inc. MARIN, DAKOTA 3732 §101§102§103§112 Non-Final OA — Pending Aug 06, 2025
19292344 METHODS AND SYSTEMS FOR NEURAL STIMULATION VIA VISUAL, AUDITORY AND PERIPHERAL NERVE STIMULATIONS Cognito Therapeutics, Inc. MALAMUD, DEBORAH LESLIE 3792 §102§103§112 Final Rejection 20d Pending Aug 06, 2025
19274214 DEEP LEARNING-BASED METHODS, DEVICES, AND SYSTEMS FOR PRENATAL TESTING Nucleix Ltd. PATEL, JAY M 3681 DP Non-Final OA — Pending Jul 18, 2025
19236720 METHODS, COMPOSITONS AND SYSTEMS FOR ANALYTE DETECTION Stellaromics, Inc. SISSON, BRADLEY L 1682 §103 Final Rejection — Pending Jun 12, 2025
19219221 SOLOR TRACKER AND CONTROL METHOD OF THE SOLAR TRACKER P4Q Electronics S.L. TRINH, THANH TRUC 1726 §103 Non-Final OA — Pending May 27, 2025
19211711 MULTISPACE PARKING PAY STATIONS INCLUDING PAYMENT IMPROVEMENTS Ips Group Inc. VANDERHORST, MARIA VICTORIA 3621 §101§103 Non-Final OA — Pending May 19, 2025
19205306 SYSTEMS AND METHODS FOR DATA QUALITY AND VALIDITY IMPROVEMENT IN EDUCATION INSTITUTIONAL, DEGREE, AND COURSE LICENSE MANAGEMENT Woolf Inc. HARRIS, CHRISTOPHER C 2432 §101§112 Non-Final OA — Pending May 12, 2025
19199682 Methods and Systems for Evaluation of Lupus Based on Ancestry-Associated Molecular Pathways Ampel Biosolutions, LLC PAULSON, SHEETAL R. 3615 §101§102 Final Rejection — Pending May 06, 2025
19196360 SYSTEMS AND METHODS FOR MEDICAL IMAGING GATEWAYS Alara Imaging Inc. HUANG, KAYLEE J 2447 §101§102§103§112Other Non-Final OA — Pending May 01, 2025
19190170 SPECTROMETRY SYSTEMS WITH DECREASED LIGHT PATH Scio Solutions Ltd. NUR, ABDULLAHI 2877 DP Non-Final OA — Pending Apr 25, 2025
19184633 SYSTEMS, METHODS, SOFTWARE, AND PLATFORMS FOR CLINICAL DECISION SUPPORT Triaj, Inc. CHOI, PETER H 3681 §101§103§112 Non-Final OA — Pending Apr 21, 2025
19113337 USE OF AN EMULSIFIER DERIVED FROM RICINOLEIC ACID TO INCREASE THE ABSORPTION OF CALCIUM AND PHOSPHORUS IN THE DIGESTIVE TRACT OF FARM ANIMALS Gfs Industria De Alimentação Animal Ltda YOO, HONG THI 1792 §103§112 Non-Final OA — Pending Mar 19, 2025
19082739 SYSTEMS AND METHODS FOR ROBOTIC ENDOSCOPE BENDING SECTION Noah Medical Corporation SHARPLESS, CHRISTEN ALICIA 3795 §102§103 Non-Final OA — Pending Mar 18, 2025
19082681 SYSTEMS AND METHODS FOR ROBOTIC ENDOSCOPE SYSTEM UTILIZING TOMOSYNTHESIS AND AUGMENTED FLUOROSCOPY Noah Medical Corporation LUU, TIMOTHY TUAN 3795 §102§103 Non-Final OA — Pending Mar 18, 2025
19069080 SYSTEMS AND METHODS FOR HEMOGLOBIN LEVEL DETERMINATION Monere Corporation PATEL, NIDHI NIRAJ 3791 §103 Non-Final OA — Pending Mar 03, 2025
19067593 TEMPORARY VASCULAR SCAFFOLD AND SCORING DEVICE Nfinium Vascular Technologies, LLC RWEGO, KANKINDI 3771 §112Other Non-Final OA — Pending Feb 28, 2025
19058491 SYSTEMS AND METHODS FOR CONTRAST-ENHANCED MRI Subtle Medical, Inc. WINDSOR, COURTNEY J 2661 §112 Non-Final OA — Pending Feb 20, 2025
19054472 SYSTEMS AND METHODS FOR WASTEWATER HEAT RECOVERY Epic Cleantec Inc. ARANT, HARRY E 3763 §103 Non-Final OA 82d Pending Feb 14, 2025
19054041 ITEM MANIPULATION SYSTEM AND METHODS Nomagic sp z o.o. MANCHO, RONNIE M 3657 §112 Final Rejection — Pending Feb 14, 2025
19053307 COMPOSITIONS AND METHODS FOR REDUCING GREENHOUSE GAS Rumin8 Pty Ltd. SWEENEY, MAURA ELIZABETH 1791 §103§112 Non-Final OA — Pending Feb 13, 2025
19049689 METHOD FOR OBTAINING A LIGNOCELLULOSIC COMPOSITE MATERIAL AND COMPOSITE MATERIAL OBTAINED THEREOF SAS Woodoo SWANSON, ANDREW L 1745 §102§103 Non-Final OA — Pending Feb 10, 2025
19045764 IMIDAZO[1,2-C]PYRIMIDINE DERIVATIVES AS PRC2 INHIBITORS FOR TREATING CANCER Mirati Therapeutics, Inc. SANCHEZ, JUSTIN CHRISTOPHER 1622 §112DP Non-Final OA — Pending Feb 05, 2025
19038867 COMPOSITIONS COMPRISING CYSTEINE PRODRUGS AND METHODS USING THEREOF Nature'S Fusions, LLC ROSSI, JULIA ANNE LORRAIN 1615 §103§112 Non-Final OA — Pending Jan 28, 2025
19038117 METHODS AND SYSTEMS FOR REMOTE OPERATION OF VEHICLE Rotor Technologies, Inc. HOLWERDA, STEPHEN 3656 §101§102§112 Non-Final OA — Pending Jan 27, 2025
19030061 COMPOSITIONS AND METHODS FOR PRODUCING FOOD PRODUCTS WITH RECOMBINANT ANIMAL PROTEIN Bond Pet Foods, Inc. ROBINSON, HOPE A 1652 §112 Non-Final OA — Pending Jan 17, 2025
19030518 AMORPHOUS (A-POLYMORPHIC) PSILOCYBIN Diamond Therapeutics Inc. GONZALEZ, LUISALBERTO 1624 §103Other Non-Final OA — Pending Jan 17, 2025
19024293 DIFFRACTION-BASED GLOBAL IN VITRO DIAGNOSTIC SYSTEM Bragg Analytics, Inc. GAWORECKI, MARK R §112 Non-Final OA — Pending Jan 16, 2025
19025546 SYSTEMS AND METHODS FOR DETERMINING DATABASE PERMISSIONS Datawalk Spólka Akcyjna SKHOUN, HICHAM 2164 §102§103 Final Rejection 52d overdue Pending Jan 16, 2025
19022841 WEARABLE DEVICE TO COUNTERACT TREMOR Equibands Inc. LEBRON DE JESUS, GRACIELA NATALIA 3786 §102§103 Non-Final OA — Pending Jan 15, 2025
19018531 SYSTEMS AND METHODS FOR NUCLEAR FUSION Aquarius Energy, Inc. GARNER, LILY CRABTREE 3646 §101§102§103§112 Non-Final OA — Pending Jan 13, 2025
19016790 INHIBITORS OF ADVANCED GLYCATION END PRODUCTS Praetego Inc. PECKHAM, RICHARD GRANT 1627 §102§103§112Other Non-Final OA — Pending Jan 10, 2025
19014986 SYSTEMS AND METHODS FOR TRANSPORTING ITEMS WITHIN A NETWORK OF TUBULAR TRACK SYSTEMS Tubular Network Inc. TIGHE, BRENDAN P 3652 §102§103 Non-Final OA — Pending Jan 09, 2025
18992908 WASTEWATER PROCESSING SYSTEMS AND METHODS Eniswaterpure, LLC VARMA, AKASH K 1773 §103 Final Rejection — Pending Jan 09, 2025
19001901 SYSTEMS AND METHODS FOR ACCELERATING SPECT IMAGING Subtle Medical, Inc. CHAN, CAROL WANG 2672 §102§103§112 Non-Final OA — Pending Dec 26, 2024
18988376 BICYCLIC CARBOXAMIDES AND METHODS OF USE THEREOF Tempest Therapeutics, Inc. JACKSON, SHAWQUIA 1626 §103Other Non-Final OA — Pending Dec 19, 2024
18981846 COMPOSITIONS AND METHODS FOR EPIGENETIC EDITING Nchroma Bio, Inc. ROBINSON, HOPE A 1652 §103§112 Non-Final OA — Pending Dec 16, 2024
18980218 METHODS AND PRODUCTS FOR NUCLEIC ACID PRODUCTION AND DELIVERY Factor Bioscience Inc. LEONARD, ARTHUR S 1631 §102§103§112DP Non-Final OA — Pending Dec 13, 2024
18973406 SYSTEMS AND METHODS FOR ADJUSTING VIEWING DIRECTION Noah Medical Corporation LUU, TIMOTHY TUAN 3795 §103 Non-Final OA — Pending Dec 09, 2024
18971494 SYSTEMS AND METHODS FOR ROBOTIC BRONCHOSCOPY NAVIGATION Noah Medical Corporation WOO, JAE KYUN 3795 §102§103 Non-Final OA — Pending Dec 06, 2024
18955505 AKT1 MODULATORS Alterome Therapeutics, Inc. RODRIGUEZ-GARCIA, VALERIE 1621 §112 Non-Final OA — Pending Nov 21, 2024
18867628 CRYSTAL FORMS OF TRIAZINE DIONE DERIVATIVE AND PREPARATION METHOD THEREFOR Jiangsu Hengrui Pharmaceuticals Co., Ltd. KOSACK, JOSEPH R 3991 §112 Non-Final OA — Pending Nov 20, 2024
18951298 METHODS AND APPARATUS FOR EVALUATING DEVELOPMENTAL CONDITIONS AND PROVIDING CONTROL OVER COVERAGE AND RELIABILITY Cognoa, Inc. WILLIAMS, TERESA S 3687 §101§102§103 Non-Final OA — Pending Nov 18, 2024
18951439 SECURE ELECTRIC VEHICLE CHARGER AND SYSTEM INCORPORATING THEREOF Eve Energy Ventures Inc. WRIGHT, BRYAN F 2497 §103 Non-Final OA — Pending Nov 18, 2024
18948178 METHODS AND SYSTEMS FOR GENERATING HIGH-CONTRAST ARRAYS Atom Computing Inc. KIM, ROBERT H 2881 §102§103 Non-Final OA — Pending Nov 14, 2024
18947045 THERAPEUTIC VARIANT ALPHA-2-MACROGLOBULIN COMPOSITIONS Cytonics Corporation NOAKES, SUZANNE MARIE 1656 §102§112DP Non-Final OA — Pending Nov 14, 2024
18941418 DEVICES FOR BIOLOGICAL ANALYSIS Cellsbin, Inc. UNDERWOOD, JARREAS C 2877 §103 Final Rejection — Pending Nov 08, 2024
18940597 THERAPEUTIC USES OF GLP1R AGONISTS Vtv Therapeutics LLC BORI, IBRAHIM D 1629 §103§112DP Non-Final OA — Pending Nov 07, 2024
18938630 MICROORGANISMS AND ARTIFICIAL ECOSYSTEMS FOR THE PRODUCTION OF PROTEIN, FOOD, AND USEFUL CO-PRODUCTS FROM C1 SUBSTRATES Kiverdi, Inc. ARIANI, KADE 1651 §101§102§112Other Non-Final OA — Pending Nov 06, 2024
18931558 CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO Thornhill Therapeutics, Inc. ZEMAN, ROBERT A 1645 §102§103Other Non-Final OA — Pending Oct 30, 2024
18929252 WEARABLE DEVICE TO TREAT TREMOR Equibands Inc. JONES, AISLINN MOIRA 3785 §103§112 Non-Final OA — Pending Oct 28, 2024
18928814 BETA-LACTAM DERIVATIVES FOR THE TREATMENT OF DISEASES Insilico Medicine Ip Limited DAVIS, BRIAN J 1614 §112DP Non-Final OA — Pending Oct 28, 2024
18860464 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS Retune Pharma Inc. SOROUSH, ALI 1629 §112 Non-Final OA — Pending Oct 25, 2024
18926142 TOXIN-DERIVED DELIVERY CONSTRUCTS Thornhill Therapeutics, Inc. TSAY, MARSHA M 1656 §103DP Non-Final OA — Pending Oct 24, 2024
18924896 COMPLEX IMAGE DATA ANALYSIS USING ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING ALGORITHMS Sirona Medical, Inc. BAKER, CHARLOTTE M 2664 §102 Non-Final OA — Pending Oct 23, 2024
18922750 APPARATUS AND METHOD FOR CHARACTERIZATION OF ACUTE OTITIS MEDIA Otonexus Medical Technologies, Inc. BRUTUS, JOEL F 3797 §103 Final Rejection 35d overdue Pending Oct 22, 2024
18921391 ECG PATCH AND METHODS OF USE Lifesignals, Inc. DOWNEY, JOHN R 3792 §102§103§112 Non-Final OA — Pending Oct 21, 2024
18917796 COMPOUNDS AND METHODS FOR MODULATING HER2 Iambic Therapeutics, Inc. SHIAO, REI TSANG 1691 DP Non-Final OA — Pending Oct 16, 2024
18913757 METHODS AND PRODUCTS FOR TRANSFECTION Factor Bioscience Inc. NOBLE, MARCIA STEPHENS 1632 DP Non-Final OA — Pending Oct 11, 2024
18909740 METHODS AND SYSTEMS FOR MONITORING SLEEP ACTIVITY AND PROVIDING A TREATMENT Somnology, Inc. ROBERTS, ANNA L §101§103 Non-Final OA — Pending Oct 08, 2024
18907033 MACHINE LEARNING FOR OTITIS MEDIA DIAGNOSIS Otonexus Medical Technologies, Inc. STREGE, JOHN B 2669 §103Other Non-Final OA — Pending Oct 04, 2024
18904684 SENSOR-BASED MACHINE LEARNING IN A HEALTH PREDICTION ENVIRONMENT Evidation Health, Inc. MISIASZEK, AMBER ALTSCHUL 3682 §101§103 Final Rejection 23d overdue Pending Oct 02, 2024
18903228 INHIBITORS OF ADVANCED GLYCATION END PRODUCTS Praetego Inc. PECKHAM, RICHARD GRANT 1627 §103§112DP Non-Final OA — Pending Oct 01, 2024
18903693 SYSTEMS AND METHODS FOR ANOMALY DETECTION USING EXPLAINABLE MACHINE LEARNING ALGORITHMS Hawk AI GmbH MAGUIRE, LINDSAY M 3619 §101 Non-Final OA 9d Pending Oct 01, 2024
18894460 APPARATUS FOR MANIPULATION OF EAR DEVICES Earplace Inc. SHAH, JAY B 3791 §102§103§112 Non-Final OA — Pending Sep 24, 2024
18891790 PHENOTYPE MEASUREMENT SYSTEMS AND METHODS Fenologica Biosciences, Inc. GILLIARD, DELOMIA L 2661 §103DP Non-Final OA — Pending Sep 20, 2024
18890248 INHIBITORS OF MEK KINASE Mosaica Medicines, Inc. STOCKTON, LAURA LYNNE 1626 DP Non-Final OA — Pending Sep 19, 2024
18890562 INTEGRATED PLATFORM FOR DIGITAL ASSET REGISTRATION, TRACKING AND VALIDATION Figure Lending Corporation SHARON, AYAL I 3695 §101§103 Final Rejection — Pending Sep 19, 2024
18883711 ARTIFICIAL INTELLIGENCE PHYSICS-BASED MODELING OF CARDIAC PARAMETERS Delbeat, Inc. HAKALA, ALAN GREGORY 2617 §102§103 Non-Final OA 14d Pending Sep 12, 2024
18824159 METHODS AND SYSTEMS FOR CHROMATOGRAPHIC DETERMINATION OF A METABOLOME Park City Venture Partners, LLC SANGHERA, STEVEN G.S. 3684 §101§102§103§112 Final Rejection 51d overdue Pending Sep 04, 2024
18823526 MICROORGANISMS AND ARTIFICIAL ECOSYSTEMS FOR THE PRODUCTION OF PROTEIN, FOOD, AND USEFUL CO-PRODUCTS FROM C1 SUBSTRATES Kiverdi, Inc. ARIANI, KADE 1651 §112DP Non-Final OA — Pending Sep 03, 2024
18823534 MICROORGANISMS AND ARTIFICIAL ECOSYSTEMS FOR THE PRODUCTION OF PROTEIN, FOOD, AND USEFUL CO-PRODUCTS FROM C1 SUBSTRATES Kiverdi, Inc. ARIANI, KADE 1651 §112DP Non-Final OA — Pending Sep 03, 2024
18821812 METHOD AND DEVICE FOR REMOTE OPTICAL MONITORING OF INTRAOCULAR PRESSURE Smartlens, Inc. JONES, JAMES §101 Non-Final OA — Pending Aug 30, 2024
18819935 BETA-LACTAMASE INHIBITORS Venatorx Pharmaceuticals, Inc. YOO, SUN JAE 1621 Other Non-Final OA — Pending Aug 29, 2024
18818407 SURVEILLANCE SYSTEM AND METHODS FOR AUTOMATED WAREHOUSES Nomagic sp z o.o. ORTIZ ROMAN, DENISSE Y 3627 §103 Final Rejection 26d overdue Pending Aug 28, 2024
18817943 MEDIUM- OR MACRO-CYCLIC BENZYL-SUBSTITUTED HETEROCYCLE DERIVATIVES AND RELATED USES Centessa Pharmaceuticals (Uk) Limited WHITE, DAWANNA SHAR-DAY 1627 §102§103§112DP Non-Final OA — Pending Aug 28, 2024
18818005 Methods for Treating Neurodegenerative Disorders Praetego Inc. PECKHAM, RICHARD GRANT 1627 §103§112DP Non-Final OA — Pending Aug 28, 2024
18813959 COMPOSITIONS AND METHODS FOR IMPROVING COGNITIVE FUNCTION Diamond Therapeutics Inc. COPPINS, JANET L 1628 §103 Final Rejection — Pending Aug 23, 2024
18814218 EFFICIENT STORAGE AND RETRIEVAL OF SMALL OBJECTS Tigris Data, Inc. UDDIN, MD I 2169 §101§103 Non-Final OA — Pending Aug 23, 2024
18807599 INTRANASAL DELIVERY DEVICES Shin Nippon Biomedical Laboratories, Ltd. MURPHY, VICTORIA 3785 §103§112 Non-Final OA — Pending Aug 16, 2024
18806109 Unsupervised Machine Learning Methods Ampel Biosolutions, LLC DAUNER, JOSEPH G 1682 §102§103§112 Final Rejection 28d Pending Aug 15, 2024
18837846 MEMBRANE-ASSOCIATED TYROSINE- AND THREONINE-SPECIFIC CDC2-INHIBITORY KINASE (PKMYT1) INHIBITORS AND USES THEREOF Insilico Medicine Ip Limited ROBINSON, MIKHAIL O'DONNEL 1627 §103 Non-Final OA — Pending Aug 12, 2024
18799839 APPARATUS FOR WAFER HANDLING AND ALIGNMENT N&K Technology, Inc. CORTES, HOWARD 2118 §102§103 Non-Final OA — Pending Aug 09, 2024
18794589 CRYSTAL FORMS OF A POL1 INHIBITOR Pimera, Inc. KUCHARCZK, JED A 1623 DP Non-Final OA — Pending Aug 05, 2024
18835167 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS Mrja Therapeutics, Inc. PECKHAM, RICHARD GRANT 1627 §112 Non-Final OA — Pending Aug 01, 2024
18785556 METHODS AND COMPOSITIONS FOR TREATING POLYCYSTIC OVARY SYNDROME Spruce Biosciences, Inc. RAHMANI, NILOOFAR 1691 §112DP Non-Final OA — Pending Jul 26, 2024
18784718 OPHTHALMIC COMPOSITION Sydnexis, Inc. LEE, WILLIAM Y 1623 §103 Final Rejection 10d overdue Pending Jul 25, 2024
18832564 ECTONUCLEOTIDE PYROPHOSPHATASE-PHOSPHODIESTERASE 1 (ENPP1) INHIBITORS AND USES THEREOF Insilico Medicine Ip Limited CORNET, JEAN P §103 Non-Final OA — Pending Jul 24, 2024
18780961 METHODS FOR HUMAN LEUKOCYTE ANTIGEN TYPING AND PHASING Dovetail Genomics, LLC POHNERT, STEVEN C 1683 §101§103 Non-Final OA — Pending Jul 23, 2024
18730925 METHODS AND DEVICES FOR METABOLOMICS AND LIPIDOMICS ANALYSIS Seer, Inc. BRAZIN, JACQUELINE 1798 §103 Non-Final OA — Pending Jul 22, 2024
18730551 PARTICLES AND METHODS OF ASSAYING Seer, Inc. MCGUIRK, JOHN SCHUYLER 1798 §103§112 Non-Final OA — Pending Jul 19, 2024
18775447 INTRALUMINAL SUPPORT STRUCTURE AND PROSTHETIC VALVE FOR THE SAME Open Stent Solution SAS HU, ANN M 3774 §102§103§112 Non-Final OA — Pending Jul 17, 2024
18774818 Tubular Structures with Variable Support Q'Apel Medical, Inc. SWANSON, LEAH JENNINGS 3783 §102§103§112DP Non-Final OA — Pending Jul 16, 2024
18774776 Tubular Structures with Variable Support Q'Apel Medical, Inc. SWANSON, LEAH JENNINGS 3783 §102§103DP Non-Final OA — Pending Jul 16, 2024
18768466 Recovering Long-Range Linkage Information From Preserved Samples Dovetail Genomics, LLC GRAY, JESSICA 1682 §103§112DP Non-Final OA — Pending Jul 10, 2024
18727620 SYSTEMS AND METHODS FOR ASSAYING SECRETOME Seer, Inc. COLE, HOUSTON DAVID 1651 §101§102§103§112 Non-Final OA — Pending Jul 09, 2024
18763980 PARTICLES AND METHODS OF ASSAYING Seer, Inc. FRITCHMAN, REBECCA M 1758 §103§112DP Final Rejection 88d overdue Pending Jul 03, 2024
18763381 OPHTHALMIC COMPOSITION AND DELIVERY DEVICE THEREOF Sydnexis, Inc. KALIHER, HANS CHRISTIAN 3781 §103§112 Final Rejection — Pending Jul 03, 2024
18762386 RELAXATION-BASED MAGNETIC RESONANCE THERMOMETRY WITH A LOW-FIELD SINGLE-SIDED MRI SCANNER Promaxo, Inc. JASANI, ASHISH SHIRISH 3798 §103 Non-Final OA 63d Pending Jul 02, 2024
18756287 SYSTEMS AND METHODS FOR DETERMINING AND QUANTIFYING IMAGE DATA Gauss Labs Inc. LI, RUIPING 2676 §103 Final Rejection — Pending Jun 27, 2024
18754637 STEM CELL STIMULATING COMPOSITIONS AND METHODS Medicell Technologies LLC HIRT, ERIN E 1616 §102§103Other Final Rejection — Pending Jun 26, 2024
18753922 Secure Electric Vehicle Charger and System Incorporating Thereof Eve Energy Ventures Inc. WRIGHT, BRYAN F 2497 §103§112 Final Rejection 52d overdue Pending Jun 25, 2024
18752362 Unsupervised Machine Learning Methods Ampel Biosolutions, LLC CLOW, LORI A 1687 §101§102§112 Non-Final OA — Pending Jun 24, 2024
18722528 METHODS AND COMPOSITIONS FOR IMPROVED MOLECULAR THERAPIES OF MULTIGENIC DISEASES Land Medicine Inc. CANDELARIA, JULIANA IRENE 1634 §103§112 Non-Final OA — Pending Jun 20, 2024
18738282 SYSTEMS AND METHODS FOR POSE ESTIMATION OF IMAGING SYSTEM Noah Medical Corporation SHENG, CHAO 3797 §103§112 Final Rejection — Pending Jun 10, 2024
18734772 COMPOSITIONS AND METHODS FOR RNA SYNTHESIS Linearx, Inc. REGA, KYLE THOMAS 1636 §112 Final Rejection 9d Pending Jun 05, 2024
18716877 PHOSPHITE DEHYDROGENASE AS A SELECTABLE MARKER FOR MITOCHONDRIAL TRANSFORMATION Napigen, Inc. DEVEAU ROSEN, JASON 1662 §103 Final Rejection 10d overdue Pending Jun 05, 2024
18732126 SYSTEMS AND METHODS FOR ANALYZING A TARGET MOLECULE Axbio Inc. GIAMMONA, FRANCESCA FILIPPA 1681 §103 Final Rejection — Pending Jun 03, 2024
18675540 COMPOSITIONS AND METHODS FOR ARUNDO PLANT BIOMASS PRODUCTION Hexas Biomass Inc. GILLETT, JENNIFER ANN 1786 §102§103§112 Non-Final OA — Pending May 28, 2024
18675757 AGRICULTURAL SYSTEM FOR LOW AND HIGH-RESOLUTION SPOT SPRAYING AND METHOD FOR OPERATING SUCH A SYSTEM Ecorobotix SA LIU, JINGCHEN 3741 §102§103§112 Final Rejection — Pending May 28, 2024
18714015 CRYSTALLINE FORMS OF A COMPOUND FOR TREATING OR PREVENTING GOUT OR HYPERURICEMIA Arthrosi Therapeutics, Inc. GONZALEZ, LUISALBERTO 1624 §102§112 Non-Final OA — Pending May 28, 2024
18672017 LIGHT-BASED MEDICAL DEVICE Illumisen, Inc. CATTUNGAL, SANJAY 3798 §102Other Non-Final OA — Pending May 23, 2024
18668242 Aortic Heart Valve Devices Raghuveer Basude PRESTON, REBECCA STRASZHEIM 3774 §103§112 Non-Final OA — Pending May 19, 2024
18667884 TREATMENT OF RESTENOSIS USING TEMSIROLIMUS Mercator Medsystems, Inc. RAHMANI, NILOOFAR 1691 §101§102§103§112DP Non-Final OA — Pending May 17, 2024
18665851 DENDRIMERS FOR GENOMIC ANALYSIS METHODS AND COMPOSITIONS Dovetail Genomics, LLC GIAMMONA, FRANCESCA FILIPPA §103§112Other Non-Final OA — Pending May 16, 2024
18666699 PYRIDAZINONE COMPOUNDS AND USES THEREOF Edgewise Therapeutics, Inc. STOCKTON, LAURA LYNNE 1626 §102§103§112 Non-Final OA — Pending May 16, 2024
18666047 SHELF-STABLE FORMULATIONS OF BENZOYL PEROXIDE AND METHODS OF PRODUCING SAME BLUE HILL TECHNOLOGIES LLC DONOHUE, SEAN R 1618 §103 Final Rejection 105d overdue Pending May 16, 2024
18664554 METHODS AND COMPOSITIONS FOR TREATING CANCER Onconova Therapeutics, Inc. ANDERSON, REBECCA L 1626 §103 Non-Final OA — Pending May 15, 2024
18662754 METHODS AND SYSTEMS FOR AUDIO SAMPLE QUALITY CONTROL Clearspeed Inc. SHAH, ANTIM G 2693 §103 Non-Final OA 38d overdue Pending May 13, 2024
18709430 PNEUMATOSPUN BIOPOLYMER SCAFFOLDS AND METHODS FOR THEIR PRODUCTION Scripps Health GHERBI, SUZETTE JAIME J 3774 §102§103 Non-Final OA — Pending May 10, 2024
18708947 THIOPHENE ULK1/2 INHIBITORS AND THEIR USE THEREOF Erasca, Inc. ROMERO, KRISTEN WANG 1624 §102§112 Non-Final OA — Pending May 09, 2024
18659544 MULTIFUNCTIONAL MOLECULES AND USES THEREOF Marengo Therapeutics, Inc. HOPKINS, SAMANTHA LAKE 1641 §102§103§112DP Non-Final OA — Pending May 09, 2024
18658055 LOW INTENSITY FOCUSED ULTRASOUND FOR TREATING CANCER AND METASTASIS Albert Einstein College of Medicine LUONG, PETER 3797 §103Other Final Rejection 27d Pending May 08, 2024
18658491 COMPACT AUTO-INJECTOR Pirouette Pharma Inc. SHAH, NILAY J 3783 §102§103 Non-Final OA — Pending May 08, 2024
18657531 SYSTEMS AND METHODS FOR RESPONSIVE INSERTION AND RETRACTION OF ROBOTIC ENDOSCOPE Noah Medical Corporation BOICE, JAMES EDWARD 3795 §103Other Final Rejection 59d overdue Pending May 07, 2024
18656385 ONCOSELECTIVE CANCER THERAPY Kernal Biologics, Inc. CHONG, KIMBERLY 1636 §112 Non-Final OA — Pending May 06, 2024
18656278 SYSTEMS AND METHODS FOR STOOL CHARACTERIZATION AS NON-INVASIVE MEASURES OF DISEASE ACTIVITY Cylinder Health, Inc. RUIZ, JOSHUA DAMIAN 3684 §101 Non-Final OA 30d overdue Pending May 06, 2024
18652545 PRESSURE SAFETY DEVICE FOR BAG VALVE MASK Safebvm DITMER, KATHRYN ELIZABETH 3785 §101§103§112Other Non-Final OA — Pending May 01, 2024
18652456 SYSTEMS AND METHODS FOR ENDOSCOPE PROXIMAL END DESIGN Noah Medical Corporation HUYNH, AN SON PHI 3795 §102§103§112 Non-Final OA — Pending May 01, 2024
18706534 METHODS AND SYSTEMS FOR SUPER-RESOLUTION STUDY OF THERAPIES Toreador Therapeutics, Inc. MARCSISIN, ELLEN JEAN §103§112 Non-Final OA — Pending May 01, 2024
18705742 SARS-COV-2 INHIBITORS FOR TREATING CORONAVIRUS INFECTIONS Insilico Medicine Ip Limited HASTINGS, ALISON AZAR 1629 §103Other Final Rejection — Pending Apr 29, 2024
18649700 ANALYZING PHENOTYPES OF CELLS Deepcell, Inc. LANTZ, KARSTEN FOSTER 2664 §103§112 Non-Final OA — Pending Apr 29, 2024
18704831 MULTISPECIFIC ANTIBODIES FOR TREATING CD47-ASSOCIATED DISEASES Virtuoso Binco, Inc. ALLEN, MARIANNE P 1647 §112 Non-Final OA — Pending Apr 25, 2024
18704366 PROLYL HYDROXYLASE DOMAIN-CONTAINING PROTEIN (PHD) INHIBITORS AND USES THEREOF Insilico Medicine Ip Limited O DELL, DAVID K 1621 DP Non-Final OA — Pending Apr 24, 2024
18704395 IFENPRODIL SALTS AND THERAPEUTIC USES THEREOF Algernon Pharmaceuticals Inc. LADD, CAROLYN LOUISE 1622 §103 Non-Final OA — Pending Apr 24, 2024
18702652 (S)-1-(1-ACRYLOYLPIPERIDIN-3-YL)-2-FLUORO-5,6,7,8,9,10-HEXAHYDROCYCLO HEPTA[B]INDOLE-4-CARBOXAMIDE, AND RELATED CRYSTALLINE FORMS, COMPOSITIONS, AND METHODS THEREOF Vidya Therapeutics, Inc. LEE, WILLIAM Y 1623 §102§103 Non-Final OA — Pending Apr 18, 2024
18637810 COMPOSITIONS AND METHODS FOR NEUTRALIZING ANTIGENS Pacagen, Inc. XIAO, YAN 1642 §112 Non-Final OA — Pending Apr 17, 2024
18636423 SYSTEMS AND METHODS FOR MULTI-CONTRAST MULTI-SCALE VISION TRANSFORMERS Subtle Medical, Inc. LY, TOMMY TAI 3797 §103§112 Final Rejection 43d overdue Pending Apr 16, 2024
18636128 SYSTEMS AND METHODS FOR EARLY-STAGE CANCER DETECTION AND SUBTYPING Exai Bio Inc. GIROUX, GEORGE 2128 §101§103 Non-Final OA — Pending Apr 15, 2024
18699841 TYRO3 INHIBITORS Halia Therapeutics, Inc. KENYON, JOHN S 1625 §102§112 Non-Final OA — Pending Apr 09, 2024
18628411 TIDAL VOLUME, PRESSURE, INSPIRATORY TIME, AND VENTILATION RATE MEASUREMENT DEVICE DURING MANUAL VENTILATION Safebvm Corp. SIPPEL, RACHEL T 3785 §103§112 Non-Final OA — Pending Apr 05, 2024
18626751 TREATMENT OF HYPERTENSION BY RENAL VASCULAR DELIVERY OF GUANETHIDINE Mercator Medsystems, Inc. GRAY, PHILLIP A 3783 §103 Non-Final OA — Pending Apr 04, 2024
18627264 LOW-AREA, LOW-POWER NEURAL RECORDING CIRCUIT, AND METHOD OF TRAINING THE SAME Caeleste Cvba D ABREU, MICHAEL JOSEPH 3796 §102 Non-Final OA 28d overdue Pending Apr 04, 2024
18618157 METHODS FOR CATEGORIZING DISEASE OUTCOMES Kosuke Yoshida JONES, CHRISTINE MICHELLE 1682 §101§103§112DP Non-Final OA — Pending Mar 27, 2024
18614468 METHODS AND SYSTEMS FOR EIGENSTATE PREPARATION OF A TARGET HAMILTONIAN ON A QUANTUM COMPUTER 1QB Information Technologies Inc. NGUYEN, CHAU T 2145 §102 Non-Final OA — Pending Mar 22, 2024
18694836 PYRROLE[2,3-B]PYRIDINE DERIVATIVES AS TYRO3 INHIBITORS Halia Therapeutics, Inc. OTTON, ALICIA L 1699 §112 Non-Final OA — Pending Mar 22, 2024
18612234 COMPOSITIONS, SYSTEMS, AND METHODS FOR DATA STORAGE USING NUCLEIC ACIDS AND POLYMERASES Naio, Inc. RILEY, JEZIA 1681 §102§112Other Non-Final OA — Pending Mar 21, 2024
18607804 ULTRA-HIGH RESOLUTION CT RECONSTRUCTION USING GRADIENT GUIDANCE Subtle Medical, Inc. ALFONSO, DENISE G 2662 §103 Final Rejection 26d overdue Pending Mar 18, 2024
18607814 SYSTEMS AND METHODS FOR CONTRAST DOSE REDUCTION Subtle Medical, Inc. ALFONSO, DENISE G 2662 §103 Final Rejection 26d overdue Pending Mar 18, 2024
18605303 SYSTEMS AND METHODS FOR LASER-BASED MEDICAL DEVICE ILLUMINATION Noah Medical Corporation STARKEY, OLIVIA GRACE 3795 §103 Non-Final OA — Pending Mar 14, 2024
18691648 METHOD FOR PREPARING STRUCTURALLY COLOURED FILMS AND PIGMENTS Sparxell UK Limited WIECZOREK, MICHAEL P 1712 §102§103§112 Non-Final OA — Pending Mar 13, 2024
18602373 SYSTEMS AND METHODS FOR AUTOMATED SPINE SEGMENTATION AND ASSESSMENT OF DEGENERATION USING DEEP LEARNING Subtle Medical, Inc. YENTRAPATI, AVINASH 2672 §102§103 Final Rejection 32d overdue Pending Mar 12, 2024
18603041 SYSTEMS AND METHODS FOR COMBINING DATA ANALYSES Datawalk Spólka Akcyjna OBISESAN, AUGUSTINE KUNLE 2156 §103 Non-Final OA 12d Pending Mar 12, 2024
18603124 POLYNUCLEOTIDE CONSTRUCTS Sirius Therapeutics, Inc. BRETZ, COREY LANE 1600 §103DP Non-Final OA — Pending Mar 12, 2024
18599002 STROMAL STEM CELLS Orbsen Therapeutics Limited KNIGHT, TERESA E 1634 DP Non-Final OA — Pending Mar 07, 2024
18594668 METHODS AND COMPOSITIONS FOR DETECTION OF MUTANT NUCLEIC ACID SEQUENCES Tataa Biocenter AB JONES, CHRISTINE MICHELLE 1682 §112DP Non-Final OA — Pending Mar 04, 2024
18590521 METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE Design Therapeutics, Inc. MEAH, MOHAMMAD Y 1652 §112 Non-Final OA — Pending Feb 28, 2024
18584397 COMPOSITIONS AND METHODS FOR TRANSGENE EXPRESSION Avirmax Biopharma Inc. YU, DELPHINUS DOU YI 1636 §102§103§112 Non-Final OA — Pending Feb 22, 2024
18583551 BLOCKADE OF CD7 EXPRESSION AND CHIMERIC ANTIGEN RECEPTORS FOR IMMUNOTHERAPY OF T-CELL MALIGNANCIES National University Of Singapore KAUFMAN, CLAIRE M 1674 §112DP Non-Final OA — Pending Feb 21, 2024
18583069 METHODS OF TREATING CELIAC DISEASE Curemark, LLC PAGUIO FRISING, MICHELLE F 1651 §103§112 Non-Final OA — Pending Feb 21, 2024
18441446 SMALL MOLECULE MODULATORS OF FERROPTOSIS Arpeggio Biosciences, Inc. SHIAO, REI TSANG 1691 §112 Non-Final OA — Pending Feb 14, 2024
18438060 METHODS OF TREATING CONGENITAL ADRENAL HYPERPLASIA Spruce Biosciences, Inc. LEE, WILLIAM Y 1623 §103§112DP Final Rejection — Pending Feb 09, 2024
18682370 PROCESS FOR PREPARING HISTONE DEMETHYLASE INHIBITORS Celgene Corporation BARSKY, JARED 1628 §112 Non-Final OA — Pending Feb 08, 2024
18436238 SYSTEMS AND METHODS FOR PROCESS MONITORING AND CONTROL Gauss Labs Inc. SHAFAYET, MOHAMMED 2893 §101§102§103§112 Non-Final OA — Pending Feb 08, 2024
18436808 TARGETING TUMOR CELLS WITH CHEMOTHERAPEUTIC AGENTS CONJUGATED TO MATRIPTASE ANTIBODIES Georgetown University STOICA, ELLY GERALD 1647 §112DP Non-Final OA — Pending Feb 08, 2024
18681811 METHOD FOR DETECTING MEDICAL CONDITIONS USING ANALYSIS OF VERY SMALL EMBRYONIC-LIKE STEM CELLS 23Ikigai Pte. Ltd. CHUNDURU, SURYAPRABHA 1681 §101§102§103Other Non-Final OA — Pending Feb 06, 2024
18681207 GROWTH HORMONE-RELEASING HORMONE PEPTIDES AND FORMULATIONS THEREOF Rebalance Health, Inc. VARADARAJ, ARCHANA 1658 §103 Non-Final OA — Pending Feb 05, 2024
18431347 SYSTEMS AND METHODS FOR INDUCING MUSCLE CONTRACTION Asayena, Inc. KUO, JONATHAN T 3792 §103§112 Final Rejection 60d overdue Pending Feb 02, 2024
18681021 METHODS AND SYSTEMS FOR PRODUCING COMPOSITE MATERIALS Applied Bioplastics Corp. WOODWARD, ANA LUCRECIA 1765 §102§103§112 Non-Final OA — Pending Feb 02, 2024
18294494 PROCESS FOR POLYAMIDE SYNTHESIS Design Therapeutics, Inc. PECKHAM, RICHARD GRANT 1627 §102§112 Non-Final OA — Pending Feb 01, 2024
18425997 SDC-2 EXOSOME COMPOSITIONS AND METHODS OF ISOLATION AND USE Orbsen Therapeutics Limited SPENCE, JENNIFER SUZANNE 1633 §101§103Other Non-Final OA 7d Pending Jan 29, 2024
18424169 MODELING DENTAL STRUCTURES FROM DENTAL SCAN Get-Grin Inc. ROSARIO, DENNIS 2676 §102§103 Non-Final OA — Pending Jan 26, 2024
18424564 METHODS AND SYSTEMS FOR PHASE GATES IN QUANTUM COMPUTERS Universal Quantum Ltd STOFFA, WYATT A 2881 §103 Non-Final OA 19d overdue Pending Jan 26, 2024
18292890 BICYCLIC PGDH INHIBITORS AND METHODS OF MAKING AND USING Epirium Bio Inc. CHENG, KAREN 1623 §102§112DP Non-Final OA — Pending Jan 26, 2024
18292856 PYRROLO[2,3-b]PYRIDINE PGDH INHIBITORS AND METHODS OF MAKING AND USING Epirium Bio Inc. LEE, WILLIAM Y 1623 §112 Non-Final OA — Pending Jan 26, 2024
18422976 SALIVA PAIRED IMAGING TEST APPARATUS AND METHOD Oral Genome Corp. COLENA, TRACY CHING-TIAN 1797 §103§112 Non-Final OA — Pending Jan 25, 2024
18419926 METHODS OF ADMINISTERING MONOMETHYL FUMARATE AND PRODRUGS THEREOF HAVING REDUCED SIDE EFFECTS Arbor Pharmaceuticals, LLC TOWNSLEY, SARA ELIZABETH 1629 §103§112 Non-Final OA — Pending Jan 23, 2024
18420123 READING METHOD OF A LATERAL FLOW TEST P4Q Health, S.L. COLE, HOUSTON DAVID 1758 §101§103 Non-Final OA — Pending Jan 23, 2024
18418855 VECTOR FOR CANCER TREATMENT Cancer Research Technology Limited BATES, KEENAN ALEXANDER 1631 §103§112 Final Rejection 92d overdue Pending Jan 22, 2024
18415394 METHODS AND DEVICES FOR CONTINUOUS OPERATION OF A COLD-ATOM DEVICE USING A SEPARATE RESERVOIR ARRAY Atom Computing Inc. COOK, BRIAN S 2187 §103 Non-Final OA 100d overdue Pending Jan 17, 2024
18578663 METHODS AND COMPOSITIONS FOR IMPROVING VISUAL FUNCTION IN OCULAR DISEASES AND DISORDERS Onl Therapeutics, Inc. COFFA, SERGIO 1658 §103§112DP Non-Final OA — Pending Jan 11, 2024
18407758 DISTORTION CORRECTION OF LOW FIELD MAGNETIC RESONANCE IMAGES WITH PAIRED HIGH FIELD MAGNETIC RESONANCE IMAGES USING MACHINE LEARNING Neuro42, Inc. KAUR, JASPREET 2662 §103 Final Rejection 80d overdue Pending Jan 09, 2024
18406859 SYSTEMS AND METHODS FOR COMBINED DETECTION OF GENETIC ALTERATIONS Predicine, Inc. HORLICK, KENNETH R 1681 §103§112 Non-Final OA — Pending Jan 08, 2024
18405378 SYSTEMS AND METHODS FOR COOLING Ferveret Inc. CAI, CHARLES J 2115 §102§103§112 Non-Final OA — Pending Jan 05, 2024
18405952 RECYCLING OF BATTERIES WITH A VACUUM CRUSHING-VAPORIZATION-COLLECTION SYSTEM Evolve Renewable Materials, Inc. VAN OUDENAREN, MATTHEW W 1728 §103§112 Non-Final OA — Pending Jan 05, 2024
18400993 THERAPEUTIC USES AND METHODS OF DELIVERY OF VISCOUS COMPOSITIONS DURING PRE AND POST SURGICAL PERIODS, FOR TREATMENT OF RESPONSIVE DISEASES OF THE EAR, NOSE AND THROAT Topical Sinus Therapeutics, Inc. HALL, DEANNA K §103 Non-Final OA — Pending Dec 29, 2023
18575016 HEPARIN FROM MODIFIED MST CELLS AND METHODS OF MAKING AND USING Tega Therapeutics, Inc. MCKNIGHT, CIARA A 1656 §102§103Other Non-Final OA — Pending Dec 28, 2023
18574148 REDUCTION OF ENDOTOXINS IN BACTERIAL PROTEIN PREPARATIONS Kiverdi, Inc. MORENO, LARK JULIA 1793 §102§103 Non-Final OA — Pending Dec 26, 2023
18395124 PARTICLE-BASED BIOSEPARATION ASSAYS Seer, Inc. COLENA, TRACY CHING-TIAN 1797 §102§103 Non-Final OA — Pending Dec 22, 2023
18392546 SYSTEMS AND METHODS FOR PREPARING IMAGING AND ANALYZING CYTOLOGIC SAMPLES Invenio Imaging, Inc. YENTRAPATI, AVINASH 2672 §103 Non-Final OA — Pending Dec 21, 2023
18573298 COMPOSITIONS OF BETA-HEXOSAMINIDASE VARIANTS AND USES THEREOF BIOMARIN PHARMACEUTICAL INC. SWIFT, CANDICE LEE 1657 §103§112 Final Rejection 4d overdue Pending Dec 21, 2023
18393292 METHODS AND SYSTEMS FOR SOLVING AN INTEGER PROGRAMMING PROBLEM OR A MIXED-INTEGER PROGRAMMING PROBLEM USING A CIRCUIT-BASED CONTINUOUS-VARIABLE QUANTUM OPTICAL DEVICE 1QB Information Technologies Inc. KWON, JUN 2127 §101§103 Non-Final OA — Pending Dec 21, 2023
18391803 SYSTEMS AND METHODS FOR WORKFLOW GENERATION Opentrons Labworks Inc. WEI, ZENGPU 2197 §103 Non-Final OA — Pending Dec 21, 2023
18390285 COMPUTER-IMPLEMENTED METHOD FOR IMPROVING QUERY EXECUTION IN RELATIONAL DATABASES NORMALIZED AT LEVEL 4 AND ABOVE Datawalk Spólka Akcyjna MARI VALCARCEL, FERNANDO MARIANO 2159 §103 Non-Final OA 74d overdue Pending Dec 20, 2023
18572087 METHODS AND SYSTEMS FOR MACHINE LEARNING ANALYSIS OF INFLAMMATORY SKIN DISEASES Ampel Biosolutions, LLC SKIBINSKY, ANNA 1635 §101§103§112 Final Rejection — Pending Dec 19, 2023
18572148 System and Method for Determining a Stool Condition Dieta Inc. MAHROUKA, WASSIM 2665 §101§103 Final Rejection 66d overdue Pending Dec 19, 2023
18541545 GENE EXPRESSION AND CELL-FREE DNA METHODS AND SYSTEMS FOR DISEASE DETECTION Accuscan Sciences Inc. BUCHANAN, BAILEY CHEYENNE 1682 §101§102§103§112 Non-Final OA — Pending Dec 15, 2023
18521970 DEVICES AND METHODS FOR CAVITY-BASED COMPUTING Atom Computing Inc. STOFFA, WYATT A 2124 §103§112DP Non-Final OA — Pending Nov 28, 2023
18563292 PENICILLIN-BINDING PROTEIN INHIBITORS Spring Mill Pharma Incorporated WARD, PAUL V 1622 §112Other Non-Final OA — Pending Nov 21, 2023
18512856 NANOPORE PROTEOMICS Rijksuniversiteit Groningen QIAN, SHIZHI 1798 §103§112 Non-Final OA — Pending Nov 17, 2023
18508585 SCALABLE NEUTRAL ATOM BASED QUANTUM COMPUTING Atom Computing Inc. SMITH, DAVID E 2881 §102§103§112 Final Rejection 12d Pending Nov 14, 2023
18507807 METHODS AND SYSTEMS FOR NUCLEIC ACID ISOLATION Seek Labs, Inc. BORTOLI, JONATHAN 1797 §102§103§112 Non-Final OA — Pending Nov 13, 2023
18506464 METHODS AND COMPOSITIONS FOR IDENTIFYING VIRAL SEQUENCES Decode Cure Limited BELLECOURT, MICHAEL JOHN ALLEN 1671 §102§103§112 Non-Final OA — Pending Nov 10, 2023
18560290 HIGH PRODUCTIVITY BIOPROCESSES FOR THE MASSIVELY SCALABLE AND ULTRA-HIGH THROUGHPUT CONVERSION OF CO2 INTO VALUABLE PRODUCTS Kiverdi, Inc. BERKE-SCHLESSEL, DAVID W 1651 §102§112DP Non-Final OA — Pending Nov 10, 2023
18506287 N6-ADENOSINE-METHYLTRANSFERASE INHIBITORS IN CANCER TREATMENT UNIVERSITY OF ZURICH SHIAO, REI TSANG 1691 §102§103 Non-Final OA — Pending Nov 10, 2023
18505006 SAMPLE PROCESSING APPARATUS AND SAMPLE PROCESSING METHOD Coyote Bioscience Co., Ltd. SIMMONS, VALERIE MICHELLE 1758 §103§112 Non-Final OA — Pending Nov 08, 2023
18503844 IDENTIFICATION AND DESIGN OF CANCER THERAPIES BASED ON RNA SEQUENCING Genomic Expression Inc. GIAMMONA, FRANCESCA FILIPPA 1681 §103 Non-Final OA — Pending Nov 07, 2023
18501238 5-HT2A AND/OR 5-HT2C RECEPTOR AGONISTS Diamond Therapeutics Inc. HABTE, KAHSAY 1624 §102§112 Non-Final OA — Pending Nov 03, 2023
18386765 METHODS AND SYSTEMS FOR SHAPING MAGNETICS FIELDS TO ALIGN FORCES ON MAGNETIC PARTICLES FOR PATIENT ANATOMY AND MOTION Otomagnetics, Inc. DECASTRO, ARIANA JOY LACAY 3791 §101§103§112 Non-Final OA — Pending Nov 03, 2023
18289399 PHARMACEUTICAL COMPOSITION FOR USE IN TREATING CEREBRAL INFARCTION Corxel Pharmaceuticals Hong Kong Limited RAO, PADMAJA S 1627 §103DP Final Rejection 12d Pending Nov 03, 2023
18501724 METHODS AND COMPOSITIONS USING AN ENGINEERED RELEASE FACTOR Opentrons Labworks Inc. MULDER, SCOTT EVAN 1656 §102§103§112 Non-Final OA 26d Pending Nov 03, 2023
18500846 SYSTEMS AND METHODS FOR AN AUTONOMOUS RIPPER Aim Intelligent Machines, Inc. JONES, JODI MARIE 3666 §103 Non-Final OA — Pending Nov 02, 2023
18491744 EXTRACELLULAR VESICLES LOADED WITH STRUCTURAL BIOMOLECULES Spot Biosystems Ltd. HUDSON, AMY ROSE 1636 §102§103§112 Non-Final OA — Pending Oct 20, 2023
18555450 NANOSCALE REACTION CHAMBERS AND METHODS OF USING THE SAME Partillion Bioscience Corporation GORDON, BRIAN R 1798 §101§112 Non-Final OA — Pending Oct 13, 2023
18482767 COMPOSITIONS AND METHODS FOR OCULAR TRANSGENE EXPRESSION Avirmax Biopharma Inc. TAKENAKA, RISA 1632 §101§103§112 Non-Final OA — Pending Oct 06, 2023
18482789 Functionalized Surfaces for Conversion of Carbon Dioxide Prometheus Fuels, Inc. WONG, EDNA 1795 §103§112 Non-Final OA — Pending Oct 06, 2023
18554283 TREATMENT OF CANCER WITH KDM4 INHIBITORS Tachyon Therapeutics, Inc. RZECZYCKI, PHILLIP MATTHEW 1624 §102§103§112DP Non-Final OA — Pending Oct 06, 2023
18554174 METHODS AND SYSTEMS FOR ANALYZING COMPLEX GENOMIC REGIONS Rprd Diagnostics, LLC CASH, KAILEY ELIZABETH 1683 §103§112DP Non-Final OA 82d Pending Oct 05, 2023
18285812 GPR119 AGONISTS Kallyope, Inc. REILLY, SOPHIA JANE 1627 §112 Non-Final OA 30d Pending Oct 05, 2023
18479335 INTRANASAL DHE FOR THE TREATMENT OF HEADACHE Satsuma Pharmaceuticals, Inc. HAGHIGHATIAN, MINA 1616 DP Non-Final OA — Pending Oct 02, 2023
17998252 METHODS FOR IDENTIFYING A MEDICAL CONDITION IN A HUMAN SUBJECT 23 Ikigai Pte. Ltd. GIAMMONA, FRANCESCA FILIPPA 1681 §101§112Other Final Rejection — Pending Sep 29, 2023
18476014 SYSTEMS FOR ASSESSING RISK OF DEVELOPING BREAST CANCER AND RELATED METHODS Gabbi, Inc. NEWTON, CHAD A 3681 §103§112 Non-Final OA — Pending Sep 27, 2023
18473089 THREE-DIMENSIONAL ORTHOSES HAVING MULTIPLE ADJUSTMENT FEATURES AND METHODS FOR THEIR MANUFACTURE AND USE Osteoid Saglik Teknolojileri A.S. NELSON, KERI JESSICA 3786 §103 Non-Final OA — Pending Sep 22, 2023
18466675 MICROBIOME IDENTIFICATION AND BACTERIOPHAGE FORMULATIONS Parallel Health, Inc. GRIZER, CASSANDRA SENN 1672 §103§112 Final Rejection 5d overdue Pending Sep 13, 2023
18462571 PROCESSES AND APPARATUS FOR EXTRACTION OF SUBSTANCES AND ENRICHED EXTRACTS FROM PLANT MATERIAL Biomass Oil Separation Solutions, LLC RAMOS LEWIS, JOSMALEN MILAGROS 1621 §102§103 Non-Final OA — Pending Sep 07, 2023
18461776 5-HT RECEPTOR AGONIST TITRATION Diamond Therapeutics Inc. BAILEY, STEVEN WILLIAM 1687 §101§102§103§112 Non-Final OA — Pending Sep 06, 2023
18462365 METHODS AND SYSTEMS FOR DROPLET MANIPULATION Volta Labs, Inc. SALMON, KATHERINE D 1682 §102§112 Non-Final OA — Pending Sep 06, 2023
18461368 ENGINEERED IMMUNE CELL THERAPIES Factor Bioscience Inc. VANHORN, ABIGAIL LOUISE 1636 §103§112DP Final Rejection 9d overdue Pending Sep 05, 2023
18453798 COMPOUNDS AND METHODS FOR MODULATING HER2 Iambic Therapeutics, Inc. PATEL, SAGAR S 1626 §112DP Final Rejection 17d overdue Pending Aug 22, 2023
18453211 IMMORTALIZED CELL LINE FOR ENGINEERED SYNTHETIC LEATHER Vitrolabs Inc. KHAN, AMINA S 1761 §103 Non-Final OA — Pending Aug 21, 2023
17914004 RESPIRATOR FACE MASKS FOR PROTECTION FROM AIRBORNE PARTICLES Encellin, Inc. EZELUOMBA, MIRIAM NCHEKWUBECHU 1776 §103 Final Rejection 16d overdue Pending Aug 18, 2023
18452480 METHODS, SYSTEMS, AND MEDIA METHOD APPLYING MACHINE LEARNING TO CHEMICAL MAPPING DATA FOR RNA TERTIARY STRUCTURE PREDICTION Atomic AI, Inc. PULLIAM, JOSEPH CONSTANTINE 1687 §101§103§112 Non-Final OA — Pending Aug 18, 2023
18451484 METHODS AND SYSTEMS FOR PROCESSING GAS STREAMS Spv Apex 1, Inc. SABOUR, GHAZAL 1686 §101§103§112 Non-Final OA — Pending Aug 17, 2023
18546941 TYK2 INHIBITORS AND USES THEREOF Sudo Biosciences Limited MOORE, SUSANNA 1624 §112Other Final Rejection — Pending Aug 17, 2023
18450775 METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE Design Therapeutics, Inc. SAEED, KAMAL A 1626 §103 Non-Final OA — Pending Aug 16, 2023
17759944 METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE Design Therapeutics, Inc. HAVLIN, ROBERT H 1626 §102 Non-Final OA 71d Pending Aug 10, 2023
18361357 IL-2 PROCYTOKINE ANTIBODY FUSION PROTEINS Proviva Therapeutics (Hong Kong) Limited TAYLOR, LIA ELAN 1641 §103§112DP Non-Final OA — Pending Jul 28, 2023
18227071 PUMP-CONNECTABLE ANALYTE SENSING CANNULA Pacific Diabetes Technologies Inc. NICHOLS, CHARLES W 3783 §103 Non-Final OA — Pending Jul 27, 2023
18358762 METHODS AND SYSTEMS FOR AUTOMATED PNEUMATIC OTOSCOPY Otonexus Medical Technologies, Inc. YOON, CHANEL J 3791 §103 Non-Final OA — Pending Jul 25, 2023
18262787 NEK7 INHIBITORS Halia Therapeutics, Inc. VAJDA, KRISTIN ANN 1622 §112 Non-Final OA — Pending Jul 25, 2023
18358886 USE OF AN EMULSIFIER DERIVED FROM RICINOLEIC ACID TO INCREASE THE ABSORPTION OF CALCIUM AND PHOSPHORUS IN THE DIGESTIVE TRACT OF FARM ANIMALS Gfsa Industria De Alimentação Animal Ltda HUANG, GIGI GEORGIANA 1613 §102§103§112DP Non-Final OA — Pending Jul 25, 2023
18354506 SYSTEMS AND METHODS FOR REAL-TIME SEARCH BASED GENERATIVE ARTIFICIAL INTELLIGENCE SuSea, Inc. RAMIREZ BRAVO, BEATRIZ A 2146 §103 Non-Final OA 73d overdue Pending Jul 18, 2023
18000108 METHOD FOR PREPARING GLP-1 RECEPTOR AGONIST FREE BASE Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. ANDERSON, REBECCA L 1626 §112 Non-Final OA — Pending Jul 17, 2023
18000102 PREPARATION METHOD FOR (S)-2-AMINO-3-(4-(2,3-DIMETHYLPYRIDIN-4-YL)PHENYL)METHYL PROPIONATE DIACID SALT Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. ANDERSON, REBECCA L 1626 Other Final Rejection — Pending Jul 17, 2023
18000099 METHOD FOR PREPARING GLP-1 RECEPTOR AGONIST Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. YOO, SUN JAE 1621 §102§112 Non-Final OA — Pending Jul 17, 2023
18347922 METHODS AND SYSTEMS OF PROCESSING COMPLEX DATA SETS USING ARTIFICIAL INTELLIGENCE AND DECONVOLUTION Cofactor Genomics, Inc. LEVERETT, MARY CHANG 1687 §102§103DP Non-Final OA — Pending Jul 06, 2023
18344616 METHODS FOR CLASSIFICATION OF LIVER DISEASE Tensor Biosciences, Inc. HOPPE, EMMA RUTH 1683 §101§102§103§112 Final Rejection 60d overdue Pending Jun 29, 2023
18270027 METHODS AND COMPOSITIONS FOR SEQUENCING LIBRARY PREPARATION Dovetail Genomics, LLC RAYMONDA, MATTHEW HAROLD 1684 §102§103§112 Non-Final OA — Pending Jun 28, 2023
18340765 ORAL DELIVERY OF THERAPEUTIC MAMMALIAN CELLS Direct Biologics, LLC MCCORMICK, CATHERINE LYNN 1638 Other Non-Final OA 54d Pending Jun 23, 2023
18212477 LONG-LIVED INSULIN DELIVERY CANNULA Pacific Diabetes Technologies Inc. STIMPERT, PHILIP EARL 3783 §102§103 Final Rejection 5d overdue Pending Jun 21, 2023
18268936 BINDER MOLECULES WITH HIGH AFFINITY AND/ OR SPECIFICITY AND METHODS OF MAKING AND USE THEREOF Alamar Biosciences, Inc. OLSON, ALEXANDRA NADINE 1684 §102§103§112 Non-Final OA — Pending Jun 21, 2023
18338049 COMPOSITIONS AND METHODS FOR EPIGENETIC EDITING Nchroma Bio, Inc. ALLEN, SARAH ELIZABETH 1637 §103Other Non-Final OA — Pending Jun 20, 2023
18336201 SYSTEMS AND METHODS FOR IDENTIFYING AND DISTINGUISHING GENETIC SAMPLES Revere Biosensors, LLC CROW, ROBERT THOMAS 1683 §103DP Final Rejection 14d Pending Jun 16, 2023
18257273 PHARMACEUTICAL FORMULATIONS OF A PHENOLIC TRPV1 AGONIST PRODRUG Vp Asset Holdings, LLC BARSKY, JARED 1628 §103Other Final Rejection — Pending Jun 13, 2023
18266970 OLIGONUCLEOTIDE ANALOGUE THERAPEUTICS FOR TREATMENT OF NEUROMUSCULAR DISEASE Neubase Therapeutics, Inc. HASTINGS, ALISON AZAR 1627 §102§103§112Other Non-Final OA 4d overdue Pending Jun 13, 2023
18257272 CRYSTALLINE FORM OF A PHENOLIC TRPV1 AGONIST PRODRUG Vp Asset Holdings LLC RICCI, CRAIG D 1611 §102 Non-Final OA — Pending Jun 13, 2023
18266793 KINASE INHIBITORS AND USES THEREOF Mosaica Medicines, Inc. ENGLISH, CONNOR KENNEDY 1625 §112 Non-Final OA — Pending Jun 12, 2023
18332906 ORAL LIQUID SUSPENSION OF PAN-RAF KINASE INHIBITOR Day One Biopharmaceuticals, Inc. MOU, LIYUAN 1628 §103§112 Final Rejection 31d overdue Pending Jun 12, 2023
18256276 HALF-LIFE EXTENDING COMPOSITIONS AND METHODS Janux Therapeutics, Inc. SAOUD, CHRISTINE J 1645 DP Final Rejection 37d overdue Pending Jun 07, 2023
18328429 SYSTEMS AND METHODS FOR PROCESSING STOOL SAMPLES Biomesense, Inc. NGUYEN, HENRY H 1758 §102§103 Final Rejection 19d Pending Jun 02, 2023
18328598 NUCLEIC ACID PRODUCTS AND METHODS OF ADMINISTRATION THEREOF Factor Bioscience Inc. ZHU, JIANJIAN 1631 §103 Final Rejection 22d Pending Jun 02, 2023
18327740 METHOD OF TREATING SCHIZOPHRENIA OR SCHIZOPHRENIFORM DISORDER Curemark, LLC BROWE, DAVID 1617 §103Other Non-Final OA 62d Pending Jun 01, 2023
18202423 SYSTEMS AND METHODS FOR DETECTING GENETIC ALTERATIONS Predicine, Inc. SWITZER, JULIET CAROLINE 1682 §103§112DP Non-Final OA 50d overdue Pending May 26, 2023
18254433 METHODS FOR CLASSIFICATION OF LIVER DISEASE Tensor Biosciences, Inc. HOPPE, EMMA RUTH 1683 §101§103 Final Rejection 146d overdue Pending May 25, 2023
18323674 LASOFOXIFENE COMBINATION TREATMENT OF ER+ BREAST CANCER THAT HAS PROGRESSED ON A CDK4/6 INHIBITOR Eli Lilly And Company NOTTINGHAM, KYLE GREGORY 1621 §102§103§112 Final Rejection 22d overdue Pending May 25, 2023
18038542 MODULAR TEXTILE RECYCLING SYSTEM AND PROCESS Ravel Holdings, Inc. ROSEBACH, CHRISTINA H.W. 1766 §103§112 Final Rejection 49d overdue Pending May 24, 2023
18318563 METHODS AND SYSTEMS FOR ANALYSIS OF MASS SPECTROMETRY DATA Seer, Inc. HILL, GRACELYN MARKHAM 2125 §101§102§103 Non-Final OA — Pending May 16, 2023
18195761 Bag System Containing a Nutrient Composition Comprising Whole Food Sole Source Meal Kate Farms, Inc. JUSTICE, GINA CHIEUN YU 1617 §103DP Final Rejection 45d overdue Pending May 10, 2023
18314090 TUMOR ACTIVATED MULTISPECIFIC ANTIBODIES FOR TARGETING CD28 AND PD-L1 AND METHODS OF USE THEREOF Janux Therapeutics, Inc. LEE, YIE CHIA 1642 §112Other Non-Final OA — Pending May 08, 2023
18314077 COMPOSITIONS AND METHODS RELATED TO TUMOR ACTIVATED ANTIBODIES TARGETING PSMA AND EFFECTOR CELL ANTIGENS Janux Therapeutics, Inc. CUNNINGCHEN, KATHLEEN MARY 1646 §112DP Final Rejection 38d overdue Pending May 08, 2023
18313146 METHODS FOR DETECTION OF NUCLEOTIDE MODIFICATION BLUECAT IP LIMITED GIAMMONA, FRANCESCA FILIPPA 1681 §103Other Final Rejection 30d overdue Pending May 05, 2023
18308318 METHODS AND COMPOSITIONS RELATING TO BIOMARKERS FOR NEURODEGENERATIVE DISEASES Anacalypsis Therapeutics, Ike BORGEEST, CHRISTINA M 1675 §101§102§103§112 Non-Final OA — Pending Apr 27, 2023
18305292 COILED COIL IMMUNOGLOBULIN FUSION PROTEINS AND COMPOSITIONS THEREOF The Scripps Research Institute NATARAJAN, MEERA 1643 §102 Non-Final OA — Pending Apr 21, 2023
18249879 ANTIBODIES TARGETING HER2 AND CD3 AND USES THEREOF Janux Therapeutics, Inc. FAUST, AMBER KATHLEEN 1643 §103Other Final Rejection 61d Pending Apr 20, 2023
18249944 TREATMENT OF HEMATOLOGICAL MALIGNANCIES WITH INHIBITORS OF MENIN Kura Oncology, Inc. SHOWALTER, ALEXANDER KEITH 1629 §103Other Final Rejection — Pending Apr 20, 2023
18249886 MULTISPECIFIC ANTIBODIES FOR TARGETING CD28 AND PD-L1 AND METHODS OF USE THEREOF Janux Therapeutics, Inc. TAYLOR, LIA ELAN 1641 §103§112 Final Rejection 33d Pending Apr 20, 2023
18302721 POLYPEPTIDES Sorriso Pharmaceuticals, Inc. SANG, HONG 1646 DP Non-Final OA — Pending Apr 18, 2023
18301361 METHODS FOR THE TREATMENT OF PRESBYOPIA Lenz Therapeutics Operations, Inc. WILSON, JERICA KATLYNN 1621 DP Final Rejection 49d overdue Pending Apr 17, 2023
18135484 VIRAL AND HOST BIOMARKERS FOR DETECTION, THERAPEUTIC EFFECTIVENESS, AND MONITORING OF CANCER LINKED TO SARS-CoV-2 AND HUMAN PAPILLOMA VIRUS Lifegene-Biomarks, Inc. CHEN, STACY BROWN 1672 §103§112 Final Rejection 60d overdue Pending Apr 17, 2023
18297574 METHOD AND SYSTEM FOR OPERATING A ROBOTIC DEVICE Tombot, Inc. MARMOR II, CHARLES ALAN 3791 §103§112 Non-Final OA — Pending Apr 07, 2023
18297328 MEDICAL INSTRUMENT AND MEDICAL METHOD FOR LOCALIZED DRUG DELIVERY Mercator Medsystems, Inc. BOSWORTH, KAMI A 3783 §103§112 Final Rejection 91d overdue Pending Apr 07, 2023
18185662 SYSTEMS AND METHODS FOR NUCLEAR FUSION Aquarius Energy, Inc. GARNER, LILY CRABTREE 3646 §101§102§112 Non-Final OA 50d Pending Mar 17, 2023
18186146 BIOPSY SYSTEM FOR ENHANCED TISSUE HARVESTING Data Driven Diagnostic Sciences, Inc., Dba D3Sciences DOUGHERTY, SEAN PATRICK 3791 §102§103§112 Non-Final OA 62d Pending Mar 17, 2023
18245410 TISSUE GRASPING DEVICES AND RELATED METHODS Medfree, Inc. LOPEZ, LESLIE ANN 3774 §112 Non-Final OA — Pending Mar 15, 2023
18245132 COMPOSITIONS AND METHODS FOR THE TREATMENT OF LIPID-RELATED DISORDERS Raziel Therapeutics Ltd. CORNET, JEAN P 1628 §102§103 Final Rejection — Pending Mar 13, 2023
18119706 METHODS, COMPOSITIONS, AND SYSTEMS FOR MAPPING LOCATIONS OF SINGLE MOLECULES IN MULTI-DIMENSIONAL SPACE 13.8, Inc. FLINDERS, JEREMY C 1684 §103DP Non-Final OA — Pending Mar 09, 2023
18114469 ORAL PHARMACEUTICAL COMPOSITION COMPRISING ZONISAMIDE AND PROCESS OF PREPARATION THEREOF Azurity Pharmaceuticals, Inc. HUANG, GIGI GEORGIANA 1613 §103§112 Final Rejection 10d overdue Pending Feb 27, 2023
18042195 METHODS FOR REDUCING MATERNAL AUTOANTIBODIES Marabio Systems, Inc. TAYLOR, LIA ELAN 1641 §103§112 Final Rejection — Pending Feb 17, 2023
18167322 METHODS AND SYSTEMS FOR DETERMINING A PREGNANCY-RELATED STATE OF A SUBJECT Mirvie, Inc. LIN, JERRY §101§103§112Other Non-Final OA — Pending Feb 10, 2023
18164542 SYSTEMS AND METHODS FOR CREATING BIOMOLECULE EMBEDDINGS Seer, Inc. THOMPSON, MILANA KAYE 1687 §103§112 Non-Final OA — Pending Feb 03, 2023
18040310 COMPOSITIONS AND METHODS FOR TREATING ALZHEIMER'S DISEASE Fortem Neurosciences, Inc. RICCI, CRAIG D 1611 §103 Non-Final OA — Pending Feb 02, 2023
18105113 SYSTEMS AND METHODS FOR MONITORING OF CANCER USING MINIMAL RESIDUAL DISEASE ANALYSIS Predicine, Inc. SCHLOOP, ALLISON ELIZABETH 1683 §101§103§112DP Non-Final OA — Pending Feb 02, 2023
18007032 SYSTEMS AND METHODS FOR ASSAYING A PLURALITY OF POLYPEPTIDES Protillion Biosciences, Inc. BUCHANAN, BAILEY CHEYENNE 1682 §103 Final Rejection — Pending Jan 26, 2023
18099240 ULTRASOUND ABLATION APPARATUS AND METHODS OF USE Current Surgical, Inc. ASGHAR, AMINAH 3797 §103 Non-Final OA — Pending Jan 19, 2023
18006142 PARTICLES AND METHODS OF ASSAYING Seer, Inc. FRITCHMAN, REBECCA M 1758 §103§112Other Final Rejection — Pending Jan 19, 2023
18014568 FETAL TROPHOBLAST COMPOSITIONS AND METHODS NextGen Jane, Inc. SCHUBERG, LAURA J 1631 §102§103 Final Rejection — Pending Jan 05, 2023
18147556 DEEP LEARNING SUPER-RESOLUTION TRAINING FOR ULTRA LOW-FIELD MAGNETIC RESONANCE IMAGING Neuro42 Inc. FRITH, SEAN A 3798 §102§103 Final Rejection — Pending Dec 28, 2022
18065103 OTOSCOPE SEAL DEVICES AND METHODS Otonexus Medical Technologies, Inc. MELHUS, BENJAMIN S 3791 §103 Final Rejection — Pending Dec 13, 2022
18064181 CELLULAR GLYCOSAMINOGLYCAN COMPOSITIONS AND METHODS OF MAKING AND USING Tega Therapeutics, Inc. FRONDA, CHRISTIAN L 1652 DP Final Rejection 45d overdue Pending Dec 09, 2022
18074659 METHODS AND SYSTEMS FOR PRECISION ONCOLOGY USING A MULTILEVEL BAYESIAN MODEL Xcures, Inc. LULTSCHIK, WILLIAM G 3685 §101§103 Final Rejection — Pending Dec 05, 2022
18061333 METHODS AND SYSTEMS FOR DROPLET MANIPULATION Volta Labs, Inc. PARISI, JESSICA DANIELLE 1684 §103 Final Rejection 91d overdue Pending Dec 02, 2022
18061310 METHODS AND SYSTEMS FOR IMPROVING AN ESTIMATION OF A PROPERTY OF A QUANTUM STATE 1QB Information Technologies Inc. VASQUEZ, MARKUS A 2121 §103§112 Final Rejection — Pending Dec 02, 2022
18059370 METHODS OF CAPTURING CELL-FREE METHYLATED DNA AND USES OF SAME Sinai Health System LU, FRANK WEI MIN 1683 §102§103§112DP Non-Final OA — Pending Nov 28, 2022
18054676 CELL-FREE DNA SIZE DETECTION Accuragen Holdings Limited SCHLOOP, ALLISON ELIZABETH 1683 §101§103§112 Final Rejection 9d Pending Nov 11, 2022
18054810 SYSTEMS AND METHODS FOR ROBOTIC ENDOSCOPIC SUBMUCOSAL DISSECTION Noah Medical Corporation BOICE, JAMES EDWARD 3795 §103 Final Rejection 87d overdue Pending Nov 11, 2022
17997688 COMPOSITIONS COMPRISING ANTI-VEGF AND NANOPARTICLES AND METHODS OF USING THE SAME FOR THE TREATMENT OF ABNORMAL OR EXCESSIVE ANGIOGENESIS Cellviva, Inc. LOCKARD, JON MCCLELLAND 1647 §102§103§112 Non-Final OA — Pending Nov 01, 2022
18046787 MESENCHYMAL STEM CELL THERAPIES Factor Bioscience Inc. FOX, ALLISON M 1633 §102§103§112 Non-Final OA — Pending Oct 14, 2022
17964399 MORTAL PLURIPOTENT STEM CELLS Accelerated Biosciences Corp. NOBLE, MARCIA STEPHENS 1632 §101§112 Non-Final OA 28d Pending Oct 12, 2022
17963362 DETECTION CIRCUIT FOR ADJUSTING WIDTH OF OUTPUT PULSES, RECEIVING UNIT, LASER RADAR Hesai Technology Co., Ltd. HODGES, SUSAN E 2425 §103 Non-Final OA 19d Pending Oct 11, 2022
17963651 SYSTEMS AND METHODS FOR ACCESS MANAGEMENT AND CLUSTERING OF GENOMIC, PHENOTYPE, AND DIAGNOSTIC DATA Ix Layer Inc. MISIASZEK, AMBER ALTSCHUL 3682 §101 Final Rejection 111d overdue Pending Oct 11, 2022
17938570 METHOD, KIT AND SYSTEM FOR SYNCHRONOUS PRENATAL DETECTION OF CHROMOSOMAL ANEUPLOIDY AND MONOGENIC DISEASE Beijing Biobiggen Technology Co., Ltd. KAPUSHOC, STEPHEN THOMAS 1683 §103 Non-Final OA — Pending Oct 06, 2022
17938284 DEVICES, SYSTEMS AND METHODS FOR ULTRA-LOW VOLUME LIQUID BIOPSY Juno Diagnostics, Inc. ZHANG, KAIJIANG 1684 §102§103§112Other Non-Final OA — Pending Oct 05, 2022
17936089 METHODS AND COMPOSITIONS FOR TREATING CANCER Engine Biosciences Pte. Ltd. VISHNYAKOVA, ELENA VLADIMIROVNA 1691 §103§112 Final Rejection 28d overdue Pending Sep 28, 2022
17946892 METHODS AND SYSTEMS FOR SORTING BIOLOGICAL PARTICLES Newomics Inc. GERHARD, ALISON CLAIRE 1797 §102§103 Final Rejection — Pending Sep 16, 2022
17930842 STEM CELL STIMULATING COMPOSITIONS AND METHODS Medicell Technologies, LLC YU, HONG 1614 §103 Non-Final OA — Pending Sep 09, 2022
17894882 OPHTHALMIC COMPOSITION Sydnexis, Inc. LEE, WILLIAM Y 1623 §103Other Final Rejection — Pending Aug 24, 2022
17894884 OPHTHALMIC COMPOSITION Sydnexis, Inc. LEE, WILLIAM Y 1623 §103Other Final Rejection 55d Pending Aug 24, 2022
17894885 OPHTHALMIC COMPOSITION Sydnexis, Inc. LEE, WILLIAM Y 1623 §103DP Final Rejection — Pending Aug 24, 2022
17880013 ACOUSTIC OTOSCOPE Otonexus Medical Technologies, Inc. DOUGHERTY, SEAN PATRICK 3791 §102§103 Final Rejection 56d Pending Aug 03, 2022
17864285 ENZYME DELIVERY SYSTEMS AND METHODS OF PREPARATION AND USE Curemark, LLC DUTT, ADITI 1675 §103DP Final Rejection — Pending Jul 13, 2022
17790797 METHODS AND COMPOSITIONS FOR PRODUCTION OF XENOGENEIC ISLET CELLS AND TREATMENT OF INSULIN-RESISTANT OR -DEFICIENT CONDITIONS WITH THE SAME Hangzhou Qihan Biotechnology Co., Ltd. NOBLE, MARCIA STEPHENS 1632 §112 Non-Final OA 9d Pending Jul 05, 2022
17855332 ANTI-TCR ANTIBODY MOLECULES AND USES THEREOF Marengo Therapeutics, Inc. PETERS, ALEC JON 1600 §102§103DP Non-Final OA — Pending Jun 30, 2022
17782010 CELL INJECTION PRINTING WITH A COAXIAL NEEDLE Scripps Health CARPENTER, WILLIAM R 3783 §102§103 Non-Final OA 42d overdue Pending Jun 02, 2022
17780227 SYSTEMS AND DEVICES FOR SAMPLE PREPARATION AND ANALYTE DETECTION Nucleix Ltd. BRAZIN, JACQUELINE 1798 §103 Final Rejection 55d Pending May 26, 2022
17824237 SOLID DISPERSION OF PAN-RAF KINASE INHIBITOR Day One Biopharmaceuticals, Inc. JANOSKO, CHASITY PAIGE 1613 §103 Final Rejection 74d overdue Pending May 25, 2022
17735084 Ionic Air Flow Generator, With Emitter And Collector Stripes Ventiva, Inc. OSENBAUGH-STEWART, ELIZA W 2881 §103§112 Final Rejection 28d overdue Pending May 02, 2022
17772829 METHODS AND SYSTEMS FOR MENSTRUALOME ANALYSIS NextGen Jane, Inc. GRAY, JESSICA 1682 §101§112DP Final Rejection — Pending Apr 28, 2022
17772832 METHODS FOR THE CHARACTERIZATION OF FLUID NextGen Jane, Inc. BICKHAM, DAWN MARIE 1685 §101§103 Non-Final OA 61d Pending Apr 28, 2022
17721831 OPHTHALMIC COMPOSITION Sydnexis, Inc. TRAN, ERIC 1629 §103 Non-Final OA 8d overdue Pending Apr 15, 2022
17719042 INHALABLE IMATINIB FORMULATION Inaya Therapeutics, Inc. LANDAU, SHARMILA GOLLAMUDI 1653 §103 Final Rejection 107d overdue Pending Apr 12, 2022
17766946 METHODS AND SYSTEMS FOR ANALYZING COMPLEX GENOMIC REGIONS Rprd Diagnostics, LLC CASH, KAILEY ELIZABETH 1683 §103Other Non-Final OA — Pending Apr 06, 2022
17706163 SYSTEMS AND METHODS OF USING SELF-ATTENTION DEEP LEARNING FOR IMAGE ENHANCEMENT Subtle Medical, Inc. GEBRESLASSIE, WINTA 2677 §103 Final Rejection — Pending Mar 28, 2022
17761696 COMPOSITIONS AND METHODS FOR TEMPLATE-FREE DOUBLE STRANDED GEOMETRIC ENZYMATIC NUCLEIC ACID SYNTHESIS Derek Stemple PARISI, JESSICA DANIELLE 1684 §103§112 Final Rejection 13d Pending Mar 18, 2022
17761866 METHOD AND SYSTEM FOR TARGETED NUCLEIC ACID SEQUENCING Jumpcode Genomics, Inc. GUSSOW, ANNE 1600 §102§103§112 Final Rejection — Pending Mar 18, 2022
17638760 HEPARIN AND HEPARAN SULFATE FROM MODIFIED MAST CELLS AND METHODS OF MAKING AND USING Tega Therapeutics, Inc. SABILA, MERCY HELLEN 1654 DP Non-Final OA 60d overdue Pending Feb 25, 2022
17635695 SYSTEMS, DEVICES, AND METHODS FOR OBSERVING A COMPUTER NETWORK AND/OR SECURING DATA ACCESS TO A COMPUTER NETWORK Arete Security Inc. Dba Druvstar VU, TAYLOR P 2437 §103§112 Final Rejection 36d overdue Pending Feb 15, 2022
17629744 IL-2 CYTOKINE PRODRUGS COMPRISING A CLEAVABLE LINKER Trutino Biosciences Inc. PATTERSON, SARAH COOPER 1675 §103§112 Final Rejection — Pending Jan 24, 2022
17578886 MACHINE LEARNING METHODS TO OPTIMIZE CONCRETE APPLICATIONS AND FORMULATIONS AlCrete Corp. REYES, MARIELA D 2142 §103 Non-Final OA 35d overdue Pending Jan 19, 2022
17578149 METHODS OF TREATING CONGENITAL ADRENAL HYPERPLASIA Spruce Biosciences, Inc. LEE, WILLIAM Y 1623 §103DP Final Rejection — Pending Jan 18, 2022
17558865 Systems and Methods for Inferring Taxonomies in Manufacturing Processes Oden Technologies Ltd. ROBINSON, GRETA LEE 2163 §103 Non-Final OA 11d overdue Pending Dec 22, 2021
17556068 METHODS AND SYSTEMS FOR IDENTIFYING TARGET GENES Algen Biotechnologies, Inc. MINCHELLA, KAITLYN L 1685 §103§112DP Non-Final OA 2d overdue Pending Dec 20, 2021
17552702 SYSTEMS AND METHODS FOR PROCESSING STOOL SAMPLES Biomesense, Inc. SIMMONS, VALERIE MICHELLE 1758 §103 Final Rejection — Pending Dec 16, 2021
17619563 A GENETIC PHARMACOPEIA FOR COMPREHENSIVE FUNCTIONAL PROFILING OF HUMAN CANCERS Function Oncology, Inc. VIJAYARAGHAVAN, JAGAMYA NMN 1633 §103§112 Final Rejection — Pending Dec 15, 2021
17616278 TUMOR ACTIVATED T CELL ENGAGERS AND METHODS OF USE THEREOF Janux Therapeutics, Inc. SHUPE, ELIZABETH A 1643 §103Other Non-Final OA — Pending Dec 03, 2021
17521286 SECRETORY PROTEIN Shanghai Puyou Biomedical Co., Ltd. AUDET, MAURY A 1654 §112 Final Rejection — Pending Nov 08, 2021
17520037 METHODS AND SYSTEMS FOR GENOME ANALYSIS University Of Utah WOITACH, JOSEPH T 1687 §101 Non-Final OA — Pending Nov 05, 2021
17606514 METHOD FOR THE TREATMENT OF PERIODONTAL DISEASE USING CHARACTERIZED MESENCHYMAL STEM CELL GROWTH FACTORS AND EXOSOMES Direct Biologics, LLC KIM, TAEYOON 1631 §103 Final Rejection — Pending Oct 26, 2021
17497373 TISSUE GRASPING DEVICES AND RELATED METHODS Medfree, Inc. PRONE, CHRISTOPHER D 3774 §102§103§112 Non-Final OA 169d overdue Pending Oct 08, 2021
17490160 METHOD OF DETERMINING PERCENTAGE OF IMMUNE CELL TYPES IN A SALIVA SPECIMEN Tru Diagnostics, Inc. JOHANSEN, PETER N. 1644 §101§102§103§112 Non-Final OA 70d Pending Sep 30, 2021
17491036 PERIVASCULAR ANTI-INFLAMMATORY THERAPY FOR VENOUS THROMBOSIS Mercator Medsystems, Inc. KOO, BENJAMIN K 3783 §103 Non-Final OA — Pending Sep 30, 2021
17598041 OPTIMIZED ULTRA-LOW VOLUME LIQUID BIOPSY METHODS, SYSTEMS, AND DEVICES Nucleix Ltd. YOUNG, BRIAN ELLIS 1684 §103 Non-Final OA — Pending Sep 24, 2021
17427192 METHODS AND COMPOSITIONS FOR DEVELOPING TARGET SPECIFIC EXOSOME AND GROWTH FACTOR PRODUCTS Direct Biologics, LLC GOLDBERG, JEANINE ANNE 1682 §103§112DP Non-Final OA 126d overdue Pending Jul 30, 2021
17427046 COMPOSITIONS AND METHODS FOR PRODUCING FOOD PRODUCTS WITH RECOMBINANT ANIMAL PROTEIN Bond Pet Foods, Inc. ROBINSON, HOPE A 1652 §112DP Non-Final OA — Pending Jul 29, 2021
17380563 SYSTEMS AND METHODS FOR ACCESS MANAGEMENT AND CLUSTERING OF GENOMIC OR PHENOTYPE DATA Ix Layer Inc. VANNI, GEORGE STEVEN 1686 §101§103§112DP Non-Final OA — Pending Jul 20, 2021
17381105 SINGLE USE DEVICES WITH INTEGRATED VISION CAPABILITIES Noah Medical Corporation WU, PAMELA F 3795 §103 Non-Final OA — Pending Jul 20, 2021
17418342 METHODS AND COMPOSITIONS FOR TREATING SKIN AND HAIR DISORDERS Direct Biologics LLC ROGERS, ERIC JASON 1638 §102§103§112DP Non-Final OA — Pending Jun 25, 2021
17196825 METHOD AND SYSTEM FOR ESTIMATING PHYSICAL QUANTITIES OF A PLURALITY OF MODELS USING A SAMPLING DEVICE 1QB Information Technologies Inc. FIGUEROA, KEVIN W 2124 §101 Non-Final OA 72d overdue Pending Mar 09, 2021
17167949 MICROFLUIDIC DEVICES AND USES THEREOF Signal Biosystems, Inc. GORDON, BRIAN R 1798 §103§112 Final Rejection 2d overdue Pending Feb 04, 2021
17031584 MICROELECTRODE ARRAY AND METHODS OF FABRICATING SAME Paradromics Inc. LEE, DAVINA EN-YIN 3794 §103 Final Rejection — Pending Sep 24, 2020
16960543 HETERODUPLEX NUCLEIC ACID MOLECULES AND USES THEREOF Atrium Therapeutics, Inc. VIVLEMORE, TRACY ANN 1638 §112Other Non-Final OA 21d Pending Jul 07, 2020
16874533 COMPOSITIONS AND METHODS FOR INCREASING THE POLLINATION PERFORMANCE OF BEES CONSEJO NACIONAL DE INVESTIGACIONES CIENTÍFICAS Y TÉCNICAS NEAGU, IRINA 1629 §103 Non-Final OA — Pending May 14, 2020
16841487 METHODS OF MANUFACTURING INJECTABLE MICROGEL SCAFFOLDS Tempo Therapeutics, Inc. HAGOPIAN, CASEY SHEA 1617 §103DP Non-Final OA 18d overdue Pending Apr 06, 2020
16718092 NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF Atrium Therapeutics, Inc. CANELLA, KAREN A 1643 §103 Final Rejection 118d overdue Pending Dec 17, 2019

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month